Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Bioceres Crop Solutions ( (BIOX) ) just unveiled an announcement.
Bioceres Crop Solutions, a Rosario, Argentina-based agbiotech group listed on Nasdaq under the ticker BIOX, develops and commercializes technologies aimed at boosting farm productivity while promoting environmentally friendly practices. Its offerings include proprietary seeds, microbial inputs, and advanced crop nutrition and protection solutions, supported by the HB4 program to provide digital decision tools and traceability for agricultural outputs.
On March 16, 2026, the company disclosed it had received a Nasdaq notice that its ordinary shares had traded below the US$1.00 minimum bid price for 30 consecutive business days, putting it out of compliance with Nasdaq Global Select Market rules. The notification does not immediately affect BIOX’s listing, and Bioceres now has until September 14, 2026, with a possible additional 180-day extension, to restore compliance by lifting its share price, a process it plans to manage by monitoring the stock closely and evaluating options to avoid potential delisting.
The most recent analyst rating on (BIOX) stock is a Sell with a $0.41 price target. To see the full list of analyst forecasts on Bioceres Crop Solutions stock, see the BIOX Stock Forecast page.
Spark’s Take on BIOX Stock
According to Spark, TipRanks’ AI Analyst, BIOX is a Neutral.
The score is held back primarily by weakening revenue and ongoing losses combined with higher leverage, despite some improvement in cash flow and margin efficiency. Technical signals remain bearish (below key moving averages with negative MACD), and valuation lacks support due to negative earnings and no dividend.
To see Spark’s full report on BIOX stock, click here.
More about Bioceres Crop Solutions
Bioceres Crop Solutions is an Argentina-based agricultural biotechnology company focused on productivity solutions that regenerate agricultural ecosystems and enhance crop resilience to climate change. Its portfolio spans patented seed and microbial inputs, as well as next-generation crop nutrition and protection products, complemented by its HB4 digital platform for grower decision support and end-to-end traceability.
Average Trading Volume: 901,487
Technical Sentiment Signal: Sell
Current Market Cap: $27.53M
Find detailed analytics on BIOX stock on TipRanks’ Stock Analysis page.